Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo

Walder, Ken; Molero, J; Konstantopoulos, Nicky; Segal, D; Foletta, Victoria; Windmill, Kelly; Curran, J; Dyer, T; Shields, K; Jowett, Jeremy; Krippner, G; Blangero, J; Collier, Gregory

Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo

conference contribution

posted on 2008-01-01, 00:00 authored by Ken WalderKen Walder, J Molero, Nicky Konstantopoulos, D Segal, Victoria Foletta, Kelly WindmillKelly Windmill, J Curran, T Dyer, K Shields, Jeremy Jowett, G Krippner, J Blangero, Gregory Collier

Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo

History

Location

Melbourne, Vic.

Open access

Yes

Start date

2008-08-28

End date

2008-08-30

Language

eng

Publication classification

E3.1 Extract of paper

Copyright notice

2008, ADS & ADEA

Title of proceedings

ADS-ADEA 2008 : Proceedings of the Australian Diabetes Society & Australian Diabetes Educators Association 2008 annual scientific meeting

Usage metrics

Keywords

Untagged

Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo

History

Location

Open access

Start date

End date

Language

Publication classification

Copyright notice

Title of proceedings

Usage metrics

Categories

Keywords

Licence

Exports